Satellite Images Show How Much Lake Mead Has Shrunk in 25 Years
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
Satellite images illustrate how water levels in Lake Mead have fallen in the past 25 years.
Why It Matters
Lake Mead supplies vital water to millions in Nevada, Arizona, California, and parts of Mexico. However, declining water levels could jeopardize city water systems, farm irrigation, and hydroelectric power output.
Lake Mead is the largest reservoir in the U.S., capable of storing approximately 29 million acre-feet of water. It is closely followed Lake Powell, with a capacity of around 25 million acre-feet.
Recent forecasts lowered runoff into Lake Powell to just 55 percent of average, down from an earlier estimate of 67 percent, due to an underwhelming winter snowpack.
Lake Mead, which receives flows from Lake Powell, hit critically low levels during the summer of 2022, following years of drought.
What To Know
Satellite imagery captured by Landsat 7, a joint mission of the United States Geological Survey (USGS) and NASA, show a stark contrast in Lake Mead's water levels between July 1999 and May 2024, with the reservoir appearing noticeably smaller in the latter image.
Landsat 7 image of the Las Vegas area and Lake Mead, acquired on July 4, 1999.
Landsat 7 image of the Las Vegas area and Lake Mead, acquired on July 4, 1999.
USGS
Landsat 7 image of the Las Vegas area and Lake Mead, acquired on May 28, 2024.
Landsat 7 image of the Las Vegas area and Lake Mead, acquired on May 28, 2024.
USGS
Images provided to Newsweek by Maxar Technologies further highlight Lake Mead's current levels compared to historical ones with the "bathtub ring" effect in display.
Recent imagery provided by Maxar Technologies shows Lake Mead in 2025, with the "bathtub ring" visible along the coastline.
Recent imagery provided by Maxar Technologies shows Lake Mead in 2025, with the "bathtub ring" visible along the coastline.
Satellite image ©2025 Maxar Technologies
Colin Williams, a mineral resources program coordinator with the USGS, told Newsweek previously that this ring around the lake is the result of calcium carbonate found in the Colorado River water. As the lake's water level fluctuates, these minerals cling to the surrounding rocks. When Lake Mead's water level drops, calcium carbonate is left behind on the rocks, forming the visible bathtub ring.
"Lake Mead is full at 1,229 feet above sea level, so the bathtub ring disappears when the lake level is near that point," Williams said at the time.
At the time of writing, Lake Mead's water levels were 1,054.85 feet mean sea level, 174.15 feet below its full pool of 1,229, according to Lakes Online, an online resource for lake and reservoir information.
What People Are Saying
Sharon Megdal, Director of the University of Arizona Water Resources Research Center, told Newsweek: "This time period has been dominated by lower annual natural river flows than those of the prior century. In addition, deliveries to water users in the Lower Basin, coupled with 1944 Treaty deliveries to Mexico have exceeded inflows, causing significant decline in the amount of water in storage since 2000.
"Despite many interventions to prop up water levels in the reservoir, "Mother Nature's flows have not been generous," Megdal added.
What Happens Next
A recent study suggested that boosting wastewater recycling to 40 percent in the Colorado River Basin could conserve about 900,000 acre-feet of water annually—enough to supply nearly two million households.
Meanwhile, the states that depend on the Colorado River have been in talks to establish new water-sharing agreements by 2026.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
3 hours ago
- Forbes
Geological Clues Connect Arizona Meteor Impact To Massive Landslide In Grand Canyon
Aerial view of Meteor Crater in Arizona. getty A new study highlights the striking coincidence in the geologic ages of the famous Meteor Crater in Arizona and a landslide dam that blocked the Colorado River, forming a paleolake in the Grand Canyon 56,000 years ago. Driftwood and lake sediments have been long known in a cave called Stanton's cave in Marble Canyon of eastern Grand Canyon. The mouth of the cave is 45 meter above the river, so how did they end up there? 'It would have required a ten-times bigger flood level than any flood that has happened in the past several thousand years. Or maybe they are very old deposits left as the river carved down, or maybe they floated in from a paleolake caused by a downstream lava dam or landslide dam? We needed to know the age of the cave deposits,' explains Karl Karlstrom, emeritus earth science professor at the University of New Mexico and lead author of the study. In the mid 1960's, Karlstrom's father, Thor, was in the cave as part of a cross-disciplinary geology-archeology research. They found evidence of species that went extinct in Grand Canyon like the California condor and Harrington's Mountain goat; they also found split twig figurines made 3,000 to 4,000 years ago by the ancestors of tribes that live around Grand Canyon. The driftwood was dated to be greater than 35,000 years which was near the limit of the radiocarbon dating method at the time; this age got recalculated in 1984 to 43,500 years. The new study, using new methods and analyses from two labs in New Zealand and Australia reports a date of 56,000 years old. In the 1980's Richard Hereford of the USGS in Flagstaff had proposed that there was a rockslide near Nankoweap Canyon, about 35 kilometers downstream of Stanton's Cave, that might have formed a dam and a paleolake that backed up water and that allowed driftwood to float into Stanton's cave. If so, driftwood should be found also in other caves, flooded at the same time. 'From numerous research trips, Karl and I knew of other high-accessible caves that had both driftwood and sediment that could be dated,' says coauthor Dr. Laurie J. Crossey. The additional wood samples provided ages around 55,600 years. In one — now almost inaccessible — cave there were even beaver tracks preserved in the sand, suggesting that high water levels persisted for quite some time. Based on sedimentation rates in the canyon, the paleolake likely existed for at least 1,000 years before filling up or breaching the landslide dam. Conceptualization of Nankoweap landslide that brought down large boulders of Kaibab Limestone from ... More the cliffs at left and created a geologically short-lived paleolake in Grand Canyon. Karl Karlstrom/University of New Mexico Landslides can be triggered by erosion, earthquakes or volcanic eruptions, but in theory also the shock waves of an asteroid impact could be Coauthor Dr. David Kring, head of the Center for Lunar Science and Exploration, University of Colorado Boulder, and an expert on the famous Meteor Crater in Arizona, had been working to recalculate the age of the crater, concluding that the impact happened 53,000 to 63,000 years ago. Was the Meteor Crater impact enough to cause such a landslide? Kring has written about the physics of this and other impacts and has calculated that the impact would have set off a magnitude 5.4 earthquake (or even M6 using different assumptions) and that the shock wave would still have been ~M3.5 after traveling (in seconds) the 160 kilometers north to Grand Canyon. So, the impact could have 'shaken loose' the steep cliffs of Grand Canyon that were 'waiting and ready to go,' as shown by numerous rock falls that happen in Grand Canyon still today. "The meteorite impact, the massive landslide, the lake deposits, and the driftwood high above river level are all rare and unusual occurrences. The mean of dates from them converge into a narrow window of time at 55,600 ± 1,300 years ago which gives credence to the hypothesis that they were causally related,' concludes Karlstrom. The full study, "Grand Canyon landslide-dam and paleolake triggered by the Meteor Crater impact at 56 ka," was published in the journal Geology and can be found online here. Additional material and interviews provided by University of New Mexico.
Newsweek
4 hours ago
- Newsweek
Massive Great White Shark Pings Off Nantucket Coast: Track Its Movements
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A colossal great white shark recently surfaced off the coast of New England — and has continued to lurk along the Atlantic coastline this summer, researchers said. The 13-foot-9-inch specimen, dubbed "Contender," weighs 1,653 pounds, marking the largest male white shark ever tagged in the western Atlantic by OCEARCH, a nonprofit marine research organization. The apex predator, first tagged in January roughly 45 miles off the Florida-Georgia coast, surfaced again last Friday about 50 miles east of Nantucket, Massachusetts, between Nantucket Shoals and Georges Bank. His beacon has not pinged since. Known as "Contender," researchers say the largest male white shark they ever tagged in the western Atlantic recently pinged off the coast of Nantucket, Massachusetts. Known as "Contender," researchers say the largest male white shark they ever tagged in the western Atlantic recently pinged off the coast of Nantucket, Massachusetts. OCEARCH "Contender's second ping on July 18 shows that he's now about 62 miles east of Nantucket Island," OCEARCH data scientist John Tyminski told Newsweek in a statement Thursday. "This movement north is typical for white sharks at this time of year — they're on their northern migration to their summer-fall foraging areas." Western North Atlantic white sharks predominantly utilize two relatively broad regions during summer and fall months, Cape Cod and Atlantic Canada, he said. "Both of these areas have healthy populations of seals which can be a rich food source especially for larger white sharks like Contender," Tyminski explained, although white sharks will also opportunistically feed on various types of fish, squid and other marine mammals. The shark, named in honor of longtime OCEARCH partner Contender Boats, had previously pinged just 22 miles off the coast of Cape Hatteras, North Carolina, researchers said in early June. Prior to last week's ping, the massive great white has been spotted off the coast of Cape Hatteras, North Carolina, in early June, researchers said. Prior to last week's ping, the massive great white has been spotted off the coast of Cape Hatteras, North Carolina, in early June, researchers said. OCEARCH "The Outer Banks is a common rest stop for these white sharks," an OCEARCH staffer wrote on Instagram. "And Contender appears to be doing just that — taking a rest. This may be due to rich food resources in this region, and it would serve as a time to feed and prepare before what may be a long journey of 1,000 miles or more up to Canada." A ping is emitted when tags attached to dorsal fins rise above the surface, transmitting real-time location data to researchers. OCEARCH has tagged 446 animals to date, according to the group's website. Visitors can track Contender and other ocean predators on OCEARCH's global shark tracker. Adult male great white sharks in the western Atlantic like Contender typically range between 11 and 13 feet, researchers said. Adult male great white sharks in the western Atlantic like Contender typically range between 11 and 13 feet, researchers said. OCEARCH "The SPOT tag deployed on Contender will provide valuable real-time data for approximately five years, helping us track his movements and understand his migration patterns," according to OCEARCH's page that monitors the shark. "Additionally, we've collected important biological samples, including urogenital material, which are currently being analyzed." While Contender represents the largest Atlantic male white shark ever to be tagged by OCEARCH, a 17-foot-2-inch female white shark named Nukumi retains the title as the largest specimen OCEARCH has ever tagged and released, Tyminski told Newsweek. Nukumi, named after a Native American mythological figure, was first tagged off Lunenberg, Nova Scotia, in October 2020 and weighed 3,541 pounds. Her last ping was transmitted in 2021, data shows. White sharks have an estimated maximum size of about 20 feet, with unconfirmed reports of some reaching up to 23 feet in length, according to the Florida Museum of Natural History. "The white shark has been credited with more fatal attacks on humans than any other species of shark," the museum's website reads. "This is due primarily to its size, power and feeding behavior."
Newsweek
13 hours ago
- Newsweek
Cancer Vaccine Breakthrough: What We Know About 'Exciting' Early Data
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Researchers at the University of Florida are moving closer to developing what they have described as a "universal" cancer vaccine, according to a study published in Nature Biomedical Engineering on July 18. The vaccine would work by "waking the immune system up against something that looks dangerous, and then that response spills over to recognize and reject the tumor," Dr. Elias Sayour, co-author of the study, director of the Pediatric Cancer Immunotherapy Initiative, and principal investigator at the RNA Engineering Laboratory at the University of Florida, told Newsweek. Sayour said that he believed the vaccine would apply to all types of cancer, because the treatment would result in the immune system being able to "recognize and reject all forms of cancer." "In active cancers, the immune system has been fooled or lies dormant," he said. "This approach can wake it up, restoring it in the fight against cancer." Sayour said that the concept of the treatment is being investigated in ongoing clinical human trials. If all goes well, it "could be a completely new paradigm to treat all cancer patients." Photo-illustration by Newsweek/Getty Most people think of vaccines as being "preventive," and taken to "prevent or lessen the impact of certain infectious diseases," David Braun, a professor of medicine and member of the Center of Molecular and Cellular Oncology at Yale Cancer Center, told Newsweek. While there are some efforts in this field for cancer, the majority of trials investigate "therapeutic" vaccines, which are used to try to treat cancer once it develops, he said. "Most cancer vaccines try to steer the immune system to attack a patient's cancer, which makes it very difficult to create a universal vaccine," Braun, who is not associated with the study, said. Referring to the study, Braun said the research team is proposing "the idea that the vaccination itself, somewhat irrespective of what it is targeting, might stimulate the immune system enough to attack cancer." "It is a very intriguing idea, but would need to be tested very carefully in clinical studies," he added. What Does This Mean for Cancer Treatment? Almost 2 million new cancer cases were reported in the United States in 2022. In 2023, more than 600,000 people died of cancer, according to the Centers for Disease Control and Prevention (CDC) data. Cancer is the second leading cause of death in the U.S., behind heart disease. In 2022, cancer accounted for almost 19 percent of deaths in the country, according to Statista data. Cancer vaccines have been approved in the past, such as Provenge, the Seattle biotech company Dendreon's shot used to treat certain forms of advanced prostate cancer. There are also others currently undergoing the clinical trial process, such as Moderna's experimental mRNA-4157 cancer vaccine, which aims to prevent the recurrence of melanoma and lung cancer and has progressed to Phase 3 in its clinical trials. However, what makes this new study notable is the fact that it is one step closer to researchers finding a vaccine to treat all types of cancer, rather than a specific type. "This strategy could be a promising neoadjuvant therapy prior to checkpoint blockades or other cancer therapies," Hua Wang, a professor of materials science and engineering at the University of Illinois Urbana-Champaign, told Newsweek. "With more success of personalized cancer vaccines, the researchers, clinicians, and the patient community will hopefully gain more confidence in cancer vaccines," Wang, who is not associated with the study, said. "At that stage, the goal of developing a universal cancer vaccine will be more reachable." Braun deemed the study "exciting early data," but told Newsweek it still has "a long path to having a major impact on the treatment of cancers in individuals." Potential Challenges While the findings are a "promising" breakthrough in cancer research, Wang said that still "rigorous safety evaluations and the optimization for therapeutic benefits are needed before this strategy can move forward." "Generally speaking, every one of us is hoping for a universal cancer vaccine that can treat or prevent different types of cancers," he said. However, Wang added that practically, "personalized" cancer vaccines are "more likely to cross the finish line because of the higher specificity and thus less off-target effects." While many types of cancer vaccines are currently being tested in clinical trials, Wang said that the challenge largely lies in "the balance of therapeutic benefits and safety." Another key issue is that "very few researchers have the resources and support needed to push forward a clinical trial on cancer vaccine," he added. Braun also said that, while cancer vaccines hold "tremendous promise," they also raise a number of open questions. "What are the best targets for the vaccine, or are more universal vaccines possible?" he said. "In what setting would a vaccine be most effective? What other types of treatments should be given together with the vaccine?" He added that in the coming years, "it will be critical to answers these questions while also having definitive clinical studies to prove that cancer vaccines help patients to live longer." Full Interview Below Q1: What does this study mean for the general public? How could this change the prevalence and treatment of cancer? Hua Wang, a professor of materials science and engineering at the University of Illinois Urbana-Champaign: "This paper reports that the early stimulation of IFN-I pathways could increase the sensitivity of poorly-immunogenic tumors to checkpoint blockades. The researchers performed the IFN-I stimulation by using unmodified mRNAs (without a specific target). This strategy could be a promising neoadjuvant therapy prior to checkpoint blockades or other cancer therapies. However, rigorous safety evaluations and the optimization for therapeutic benefits are still needed before this strategy can move forward." David Braun, a professor of medicine and member of the Center of Molecular and Cellular Oncology at Yale Cancer Center: "This study has two important goals: (1) to understand why current immune-based treatments work so well in some patients, and (2) to try to use that knowledge to design new immune treatments. In animal models, the research team is able to make tumors more sensitivity to immune therapy using this new approach. While exciting early data, we do have to remember that this is early work in animal studies, and so there is still a long path to having a major impact on the treatment of cancers in individuals." Q2: How long do you think it will be before a universal cancer vaccine is made? Wang: "Generally speaking, every one of us is hoping for a universal cancer vaccine that can treat or prevent different types of cancers. However, practically, personalized cancer vaccines are more likely to cross the finish line because of the higher specificity and thus less off-target effects. With more success of personalized cancer vaccines, the researchers, clinicians, and the patient community will hopefully gain more confidence in cancer vaccines. At that stage, the goal of developing a universal cancer vaccine will be more reachable." Braun: "When most people think of vaccines, they think of 'preventive' vaccines—the kind that children and adults typically receive to prevent or lessen the impact of certain infectious diseases. While there are some of those efforts in cancer as well, the majority of efforts are focused on 'therapeutic' vaccines, which are used to try to treat cancer once it develops. Most cancer vaccines try to 'steer' the immune system to attack a patient's cancer, which makes it very difficult to create a universal vaccine. In this study, the research team proposes a major general form of vaccination—the idea that the vaccination itself, somewhat irrespective of what it is targeting, might stimulate the immune system enough to attack cancer. It is a very intriguing idea, but would need to be tested very carefully in clinical studies." Q3: Can you foresee any challenges in the development of a cancer vaccine? If so, what are they? Wang: "Various types of cancer vaccines including neoantigen mRNA vaccines, dendritic cell vaccines, tumor exosome vaccines, nanomaterial vaccines, and biomaterial scaffold vaccines are being tested in clinical trials at the moment. The challenge largely lies in the balance of therapeutic benefits and safety, and varies for each vaccine platform. One dramatic challenge, in my opinion, is the overwhelming bar to pursuing the clinical translation of promising cancer vaccines. Very few researchers have the resources and support needed to push forward a clinical trial on cancer vaccine." Braun: "Cancer vaccines hold tremendous promise to 'steer' the immune system to attack cancer cells, but there are a number of open questions. What are the best targets for the vaccine, or are more 'universal' vaccines possible? In what setting would a vaccine be most effective? What other types of treatments should be given together with the vaccine? In the coming years, it will be critical to answer these questions while also having definitive clinical studies to prove that cancer vaccines help patients to live longer."
